Las Vegas, Nevada Doctor Selected to the "America's Best Physicians" 2018 Directory

Dr. Saleha Baig, MD, Listed as Top Doctor in Psychiatry

Dr. Saleha Baig Selected as Top Doctor in Psychiatry”

— TodaysBestPhysicians.com

LAS VEGAS, NEVADA, UNITED STATES, April 16, 2018 /EINPresswire.com/ — Las Vegas, Nevada psychiatrist Dr. Saleha Baig has been selected to the "America's Best Physicians" registry for 2018. Selections were made by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Dr. Saleha Baig practices Psychiatry at the Nevada Psychiatric Clinic, 4560 S Eastern Ave, B17 in Las Vegas, serving patients throughout Las Vegas and Henderson, Nevada.

Services include: Treatment for Attention Deficit Hyperactivity Disorder (ADHD), Autism, Post-traumatic Stress Disorder (PTSD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Opioid Withdrawal, Major Depression, Bipolar Disorder, Generalized Anxiety, Learning Disorders, Cognitive Delays, Traumatic Brain Injury and Eating Disorders.

Dr. Baig received her Medical degree (MD) from Sind Medical College and completed Psychiatry residencies at the University of Omaha and Austin State Hospital in Texas. She performed her Advanced Fellowship Training in Child and Adolescent Psychiatry at Baylor College of Medicine.

Dr. Baig is highly regarded by her patients and has numerous top reviews online. She has been selected to “The Leading Physicians of the World” and received the "Trademark Woman of Distinction" honor in 2017. She has been in practice for over 20 years.

For more information, please go to www.TodaysBestPhysicians.com or contact Dr. Saleha Baig, MD directly at 702-365-9006 or http://www.nevadapsychiatricclinic.org/.

The "National Consumer Advisory Board" accepts no fees, sponsorships, donations or advertising in their selection process. Doctors were chosen following an application based on training, experience, continuing education, and dedication to excellence. Only Doctors that satisfy all of the board's criteria can qualify for inclusion in the "Americas Best Physicians" directory.

TodaysBestPhysicians.com
Americas Best Physicians
5555555555
email us here


Source: EIN Presswire

IMIC Research gets accepted in MAGI Blue Ribbon Sites

IMIC Inc

IMIC Research

Blue Ribbon Site

IMIC Research as a research clinic in Miami and following quality review is accepted as a Blue Ribbon site in MAGI, one of the leading research organizations.

PALMETTO BAY, FLORIDA, UNITED STATES, September 30, 2018 /EINPresswire.com/ — IMIC Research is a dedicated clinical research site in Palmetto Bay, FL. The site participates in research studies sponsored by pharmaceutical companies in different fields. These studies help advance the medicine and the development of new medications.

Model Agreements & Guidelines International (MAGI) is streamlining clinical research by standardizing best practices for clinical operations, business and regulatory compliance. MAGI is one of the research organizations that host yearly research conferences to educate the research community, dedicated to advancing the practice of clinical research and provide free, highly informative, non-promotional webinars.

The MAGI Blue Ribbon Sites program promotes a culture of excellence in the clinical site community by:
-Publishing a directory of excellent sites so they can grow and do more excellent research
-Facilitating collaborations and shared best practices among the members so they can become even more excellent
-Partnering with leading product and service providers to help members find superior solutions at discounted prices
-Encouraging other sites to become excellent so they can join the program
MAGI Blue Ribbon Sites meet the following criteria:
-Have been conducting clinical research for at least five years
-Conduct enough clinical research to ensure stability (e.g., have at least two full-time study coordinators)
-Start studies quickly
-Have consistently met enrollment commitments in the past year for at least one investigator in at least one therapeutic indication
-Maintain a substantial database of potential study subjects
-Accept ethical review by accredited central IRBs, or a local IRB that meets the same standards for timeliness
-Are a member of at least one selective site network or CRO/sponsor preferred site program (preferred)
-Have a sterling reputation among study sponsors, CROs and other MAGI Blue Ribbon Sites

Having met all the above IMIC Research is accepted in The Blue Ribbon Sites Program as of 09/28/2018.

IMIC Inc is a private company in Palmetto Bay, FL. President is Aimee Cabo, CEO is Boris Nikolov. IMIC Research has been incorporated since 2006 in Florida. IMIC Research is curently working on 32 research studies as one of the dedicated sites of the global programs of many pharmaceutical companies. Current research studies are enrolling new patients in Diabetes, Asthma, Ulcerative Colitis, Crohn's disease, Liver Cirrhosis, ADHD, Tourette's syndrome, Alzheimer's disease, Bipolar disorder, NASH, among others. IMIC Research has succesfully enrolled more than 1500 patienst in more than 100 research studies in the past 10 years.

Boris Nikolov
IMIC Research
7866007005
email us here
Visit us on social media:

Facebook


Source: EIN Presswire

International Art Festival: October 4-7

“Floating around” – Anese Cho

"Blue mood 2

“Blue mood 2” – Iness Kaplun

“Meat and Bones” – Andrew Dykes

International Art Festival: October 4-7

Don't miss this great opportunity to acquire art of the highest quality, which ranges from exciting emerging artists to more established ones, many of whom are fresh to the New York art market.”

— Margo Grant, the fair's director

NEW YORK, NEW YORK, USA, September 28, 2018 /EINPresswire.com/ — In the heart of Chelsea, New York City’s premier art district, this annual international art fair highlights some of the best works by artists from across the globe who are accomplished but not yet necessarily on the radar of major institutions.

Each of the artists was carefully selected, with an eye to gathering a combination of both up-and-coming artists and more seasoned artists.

“We are extremely proud of the high quality and extraordinary variety of submissions this year, and look forward to sharing their work with the public,” said Margo Grant, the fair’s director. “Don't miss this great opportunity to acquire art of the highest quality, which ranges from exciting emerging artists to more established ones, many of whom are fresh to the New York art market."

On display will be paintings, photography, and sculpture by 40 artists: Abril Aranda, Alexander Movshovich, Alexander Rees, Amar Azad, Andrew Dykes, Anese Cho, Annette Schreiber, Brian Fass, Carole Jury, Carolin Rechberg, Chloe Kim, Christian Bakker, Emil Lansky, Emily Long, Frank Gavere, Giorgi Bliadze, Ilgin Ucar, Iness Kaplun, Inna Yudina, Jahyun Seo, Joanna Posa, Jung Lee, Kam Lucas, Katsiaryna Pratasenia, Katya Bratslavsky, Leni Berliner, Lidia Chepovetsky, Liza Cruz, Marcus Escribano, Michael Ezra, Nathan Chelnis, Nicolas Bouteneff, Nicolas Luco Ciero, Oak Chi Lee, Olga Meylakh, Robert Romano, Tony Rubino, Wenjun Fu and Yuriy Dikov.

Please join us for a champagne opening reception with the artists.

Thursday, October 4, 2018; 6-9 p.m.
Highline Loft Gallery
508 W 26th St.
New York, NY 10001

The schedule and program during the festival's other three days includes:

· Oct. 5: 12 p.m. – 7 p.m. / (Cocktail 5-7 p.m.)
· Oct. 6: 11 a.m. – 7 p.m. / (Cocktail & live music 5-7 p.m.)
· Oct. 7: 11 a.m. – 6 p.m. / (Cocktail & hors d'oeuvres 12-1 p.m.)

Michael Ezra
International Art Fair
(917) 449-2842
email us here


Source: EIN Presswire

Yellow Pages Directory Inc. Offers Annual Scholarship to Seniors Pursuing Environmental Science

White Pages Goes Green®

Yellow Pages Goes Green®

Online Phone Book Publisher offers $1,500 College scholarship annually to graduating high school seniors whose career path is related to environmental science.

The only way to combat the damage is through supporting the next wave of environmental engineers, scientists, and preservationists”

— Michael Keegan

EAST NORTHPORT, NEW YORK, USA, September 27, 2018 /EINPresswire.com/ — Yellow Pages Directory Inc., a telephone directory which supports the “Green” movement with its YellowPagesGoesGreen.org, is offering a $1,500 College scholarship to a distinguished graduating high school senior whose career path is slated to take them into any fields related to environmental preservation and environmental sciences. The goal of this scholarship is to encourage youth to pursue careers which impact Earth.

An innovator in digital telephone directory services delivers over 28.5 million Yellow Page listings and over 200 million White page listings throughout the United States. In addition, YPGG’s “Paperless Petition” was a pioneer in the phone book “opt-out” movement which helped abolish obsolete print telephone directories by prompting awareness in both creating an official opt-out process and continues to push for a national ‘opt-in’ model for printed phone books.
Those applying for the scholarship must adhere to the following strict set of criteria in order to be considered:

• Be sixteen (16) years of age or older at the time of application.
• Planning to pursue a degree directly related to environmental science or preservation.
• Be legal residents of the fifty (50) United States or the District of Columbia.
• Be enrolled (no later than fall of 2021) in an accredited post-secondary institution of higher education.
• Postal mail their written essay (scholarship Application) no later than May 31, 2019 at 11:59 pm

“The environment has sustained countless years of abuse at the hands of corporations and the only way to combat the damage is through supporting the next wave of environmental engineers, scientists, and preservationists, and that’s why we have instituted this scholarship contest. I invite any dedicated young students to get involved and submit their essay application.” said Yellow Pages Directory Inc. CEO Michael Keegan.

Yellow Pages Directory Inc., owner of both YellowPagesGoesGreen.org and PaperlessPetition.org, offers an environmentally-friendly Web-based alternative to paper telephone directories while providing a simple and convenient mechanism for customers to opt out from the receipt of printed yellow books. Both web sites have been instrumental in promoting opt-out awareness across the United States over the past several years, and allowing users to reduce their own environmental footprints in the process. Yellow Pages Directory Inc. has also taken steps to reduce its own impact on the environment through the use of the most up-to-date and energy-efficient web-hosting services available.

Official scholarship rules – including email and physical addresses to submit your essay to – can be seen by clicking here: https://www.yellowpagesgoesgreen.org/scholarship.php.

SEARCHEN NETWORKS INC.
6315877050
JOHN COLASCIONE
email us here


Source: EIN Presswire

Local Medical Startup WeShareMD Expands Into La Jolla

WeShareMD, Plans to Continue Expansion throughout Southern California, with Additional Offices Slated to Open in 2019.

LA JOLLA, SAN DIEGO, USA, September 27, 2018 /EINPresswire.com/ — The San Diego-based medical startup WeShareMD, headed by Dr. James Chao and real-estate developer George Scopetta, is expanding their footprint for the third time this year, making their total assets estimated at over $200M.

The team began their model of providing lease-free medical spaces to local doctors in their Activity Road Medical Center in San Diego, beginning early this year. Due to the demand for flexible office spaces for doctors to conveniently see patients, the startup self-funded two additional locations to open shortly thereafter, in Temecula and Encinitas.

Doctors enjoy the “WeWork” style flexible model because they can utilize the patient examination rooms that WeShareMD offers and benefit from WeShareMD’s on-site staff, medical tools and other facilities that come with a WeShareMD membership.

Member doctors have used the startup’s services to expand their medical practice to new locations or open a new medical practice of their own. Now, retiring doctors are jumping on the bandwagon as well, utilizing the startup to see their patients a few days per week and foregoing the high-costs and long leases of traditional medical office spaces.

WeShareMD is expanding into the prominent UTC area of La Jolla, CA beginning in October of 2018 and plans to continue its expansion throughout Southern California, with projections of at least 10 additional offices slated to open in 2019.

Doctors interested in joining the WeShareMD membership model can sign up with $0 sign up fees throughout 2018. All members receive access to all WeShareMD locations at a fixed price of $300 for half of a day, with discounts available on larger packages.

For more information:
www.wesharemd.com
1-832-WESHARE

Kat Levy
Do Tell PR
305-490-5911
email us here


Source: EIN Presswire

Intermountain Healthcare partners with the CDC to improve outpatient antibiotic prescribing

SALT LAKE CITY, UTAH, USA, September 27, 2018 /EINPresswire.com/ — Intermountain Healthcare has partnered with the Centers for Disease Control and Prevention (CDC) to launch a patient-centered initiative targeting outpatient antibiotic prescribing. The initiative, called the Antimicrobial Resistance Challenge, was launched at the United Nations General Assembly on September 25th and participating organizations make year-long commitments through September 2019.

Intermountain has committed to the challenge and to the White House that by 2020, it will reduce inappropriate outpatient antibiotic use for upper respiratory conditions by 50 percent. Work to get there will involve novel antibiotic prescribing metrics with prescriber feedback, electronic medical record tools, education for patients and providers, and a public awareness campaign. Intermountain will also launch the Healthy Patient Initiative to build on current infection prevention activities, including improving patient hygiene, environmental hygiene, and caregiver infection prevention.

Intermountain’s efforts are discussed in a podcast discussion with Eddie Stenehjem, MD, an infectious disease specialist and Intermountain’s Antibiotic Stewardship Medical Director, Whitney Buckel, System Antibiotic Stewardship Pharmacist Manager, and Shannon Phillips, MD, Chief Patient Experience Officer.

“The development of drug resistance leads to worse outcomes and worse patient experience,” Dr. Stenehjem says. “It leads to higher cost of care and it leads to high rates of death. We need to be stewards of these resources for generations to come. We're not going to get around this by making new drugs. We're always going to have drug resistance and so we have to slow that tide.”

Dr. Stenehjem says many patients want to be prescribed an antibiotic for every ailment, and that’s a tough expectation for prescribers to change. “This is incredibly challenging,” he says. “There’s a sentiment out there that antibiotics can fix everything and I think it's up to us as a healthcare system to help educate the public. We need to let patients know that when they come to us for an illness or for a symptom, we're going to take care of them. We're going to treat their symptoms. But that may not include an antibiotic.”

Intermountain Healthcare is a Utah-based not-for-profit system of 23 hospitals, 170 clinics, a Medical Group with about 2,300 employed physicians and advanced practice clinicians, a health plans group called SelectHealth, and other medical services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit www.intermountainhealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

SMi’s release speaker interview for Anita Burrell, speaking at Biosimilars USA conference

Biosimilars USA 2018

SMi Reports: An exclusive interview with Anita Burrell, speaker at this year’s 5th annual Biosimilars USA conference, available to download on the event website

ISELIN, NEW JERSEY, UNITED STATES , September 27, 2018 /EINPresswire.com/ — SMi Group recently caught up with expert speaker Anita Burrell, Founder & CEO at Anita Burrell Consulting, in the run up to the conference on Biosimilars USA conference, taking place in Iselin, NJ, USA on November, 14 and 15.

Anita Burrell is a dynamic, passionate and infectiously enthusiastic consultant focused on improving patient outcomes through pharmaceutical innovation. She is also an adjunct assistant professor at Rutgers University and a regular speaker in the industry on health economics, market access and mHealth.

Anita has 23 years of leadership experience in the pharmaceutical industry in a wide variety of roles and geographies. As the Global Project Lead for Aubagio, the oral MS therapy from Genzyme, she was able to bring Aubagio to market over eight months ahead of schedule becoming the second oral therapy to market in the USA and EU. Aubagio is the fastest growing MS product in the US and the #1 product in the Genzyme/Sanofi portfolio with revenue of €1.6B in 2017.
Interview Snapshot:

What is your area of expertise within the Biosimilars field and why are you supporting the Biosimilars USA conference for 2018?
My background is in value demonstration, mainly for innovative pharmaceuticals, but I became interested in the biosimilar field when I was asked a very provocative question, “Do you think that biosimilars need to have Real World Evidence?”. Given that I have a lot of experience in collecting and using RWE for pharmaceuticals I wanted to explore the question in detail and this led to a series of articles that I wrote to explore the topic. I wanted to bring this subject to the conference for the attendees, firstly as an exploration of my findings and then to continue the discussion around this topic.

What do you see as the greatest hurdle/ challenge to overcome in the Biosimilars field within the US market?
Acceptance of biosimilars in the USA has been a major issue in delivering the promise of creating financial and budgetary headroom for drugs. Market access depends on acceptance at all levels of the healthcare system, patients, physicians as well as payers and the reasons for the slower uptake can be tracked to regulatory, judicial and stakeholder reluctance. For me the main challenge for biosimilars in the US market will be dealing with these issues so that we can realize the benefits of these products and enhance the efficiency of the healthcare system in those areas where biosimilars can play a role.

What do you think could be and should be done to address this?
The FDA is already making strides to encourage the biosimilar field but there are a number of policy and regulatory barriers to…………

This year’s Biosimilars USA conference will provide delegates with the opportunity to hear from a selection of in-depth keynote addresses and case studies presented by top manufacturing and leading distributors of market-approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.

The latest conference brochure, as well as other exclusive content including the full speaker line-up and an interview with expert speaker Anita Burrell, are now available to download on the event website, where you can also register your place: www.biosimilars-usa.com/pr3

Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Biosimilars USA
14th – 15th November 2018
Renaissance Woodbridge Hotel,
Iselin, New Jersey, USA
www.biosimilars-usa.com/pr3

Follow us @SMiPharm
#SMiBioSimUSA

—- END —-

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
02078276000
email us here


Source: EIN Presswire

Global Powered Exoskeleton Market Research and Forecast 2018-2023

Powered Exoskeleton Market

Orion Market Research

Global Powered Exoskeleton Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Adoption of technology in military and defense are driving the powered exoskeleton market”

— OMR Analyst

INDORE, INDIA, September 27, 2018 /EINPresswire.com/ — According to the OMR analysis, the powered Skelton market is growing at a significant rate during 2018-2023. The powered exoskeletons are designed to physically assist and protect the wearer, which includes soldiers, construction workers and people surviving in dangerous environments. The powered exoskeleton is high-technological robotic device, which is expanding its capabilities in various fields which includes healthcare, military, industrial and others. Due to rapid development of science and technology, the powered exoskeleton is contributing in healthcare sector, and provide ways or action to mitigate neural and physical disorder. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis and analyst insights.

Full report of global powered exoskeleton market is available: https://www.omrglobal.com/industry-reports/exoskeleton-market/

The heavy weight and height of equipment’s and strict government regulations are hindering the growth of market. However, some countries are involved in identifying solutions to deal with certain issues regarding powered Skelton. The powered exoskeleton is expanding its potential in military and defense and enables in changing the world with technology. The adoption of powered exoskeleton is growing among which the US have military exoskeletons under development. Whereas the defense industry needs light weight exoskeleton with long battery life.

The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America region dominates the powered exoskeleton market, the region shows significant growth due adoption of Exoskeleton for various application, which includes medical, defense and industries are driving the US region. In medical field, it enables in lifting heavy medical apparatus and robotic assisted surgery. APAC is emerging as a growing market for this technology due to increase in demand of exoskeleton for military and defense sector. China is involved in working on next generation of military exoskeleton.

The report covers:
Comprehensive research methodology of Global Powered Exoskeleton
This report also includes detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Powered Exoskeleton Market.
Insights about market determinants which are stimulating the Global Powered Exoskeleton
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/advanced-technologies/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:

LinkedIn

Global Powered Exoskeleton Market Research By OMR


Source: EIN Presswire

Dr. Paul Pearce of Nova Biologicals to be Featured on CUTV News Radio

CONROE, TEXAS, UNITED STATES, September 27, 2018 /EINPresswire.com/ — “What an incredible privilege it is to have the opportunity to improve the quality of life for virtually all of mankind”, says Dr. Paul J. Pearce, PhD, founder of Nova Biologicals, Inc.

Microorganisms, or germs, touch the lives of every person on earth. Because many germs are potentially life threatening and because we now have the ability to manage and control some of those that impact our health and quality of life, we are able through research and testing to prevent and avoid the devastation that was, a mere 50 years ago, simply impossible. Hidden in plain sight, microorganisms can affect the food we eat, the air we breathe, the water we drink, the medical equipment we depend on and the medicines we take.

Protecting ourselves from these germs requires the diligent work of microbiological testing laboratories. Nova Biologicals specializes in testing a vast array of water, pharmaceuticals, medical devices and cosmetics.

“Microorganisms have played a huge role in the development of our civilization. There has been nothing more destructive to humanity than infection,” says Dr. Pearce. “And because of this, we realize our level of responsibility. We appreciate that responsibility and we guard that responsibility very carefully. This is a war. These organisms want to live just as much as any other organism wants to live, and they can adjust their genetics to survive in challenging environments. It’s a never-ending battle. What we do affects millions of people every day.”

As a fully certified testing laboratory, Nova recognized the enormity of the need to collaborate with individuals, industry and Federal, State and local authorities. Through this collaborative effort, Nova provides testing and consulting services that enable all parties to fulfill their responsibilities to their families, customers and citizens.

“The science is expected,” says Dr. Pearce. “It’s the ability to be responsive to what the customer needs, providing excellent science, but also understanding our clients are accountable to governmental authorities, as well as their customers and corporate stakeholders. So the culture of Nova is one of integrity, dedication, communication, and cooperation within the organization.”

A PhD in microbial immunology, Dr. Pearce spent several years working in the hospital industry as a clinical laboratory director, specializing in microbiology and the pathology of microbes before establishing Nova Biologicals 25 years ago.

Nova Biologicals began in June of 1993 testing 50 samples a month. This August, the laboratory will test between 8,000 and 10,000 samples.

“We are spreading the word about how germs impact our society. We believe that global education is necessary if we are to truly improve the quality of our lives here in America, as well as the world. We provide testing and consulting services throughout the United States of America as well as in Nicaragua, Ghana and Uganda by helping to develop water safety programs.”

CUTV News Radio will feature Dr. Pearce in an interview with Doug Llewelyn on October 1s t at 2pm EDT and with Jim Masters on October 8th at 2pm EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Nova Biologicals, visit www.novatx.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Global Medical Suction Devices Market Research and Forecast 2018-2023

Global Medical Suction Devices Market

Orion Market Research

Global Medical suction devices market, size, share, market intelligence, company profiles, market trends, strategy, analysis, forecast 2018-2023

Global medical suction devices market is growing at a steady rate due to rising demand for portable & compact devices in treatment”

— OMR Analyst

INDORE, INDIA, September 27, 2018 /EINPresswire.com/ — According to the OMR analysis, the global medical suction devices market is expected to grow at a sturdy rate over the forecast period (2018-2023). Growing demand for portable and compact devices in treatment along with increasing prevalence of chronic respiratory diseases are some of the prime factors that are significantly contributing in the growth of the market. Moreover, the technological advancement in medical suction devices such as introduction of portable mucus suction pump is expected to fuel the market growth in the near future. The global medical suction devices market is segmented on the basis of types, application, suction parts, end users, and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, patent analysis, key company analysis, market insights, company profiling, market segmentation, geographical analysis, and analyst insights.

Full report of global medical suction devices market is available at: https://www.omrglobal.com/industry-reports/medical-suction-devices-market/

“The harmonizing of medical devices market across the globe is the major factor paving the development of the medical suction devices. Rising competition among market players is leading to the development of low costlow-cost products. The U.S. has an engrained healthcare infrastructure and the presence of major players of the healthcare industry. According to International Trade Administration, in 2015, the total revenue generated by the shipment of medical devices was around $43 billion and is expected to experience 1.5% of annual growth in the medical devices industry.”
The global medical suction devices market is further analyzed on the basis of geography, which include North America, Europe, Asia- Pacific, and Rest of the World. North America has contributed a largest market share in the global medical suction devices market in 2017. Rising incidence of chronic respiratory diseases such as asthma, pulmonary hypertension, and other lung disease, is majorly driving the demand for medical suction devices in the region. The availability of favorable reimbursement policies along with the presence of major market players such as Precision Medical and Allied Healthcare Products, are some other factors augmenting the market growth in the region. Asia- Pacific is projected to exhibit the fastest growth in the global medical suction devices market over the forecast period. Rising population and rising disposable income in the region have led to a major rise in the adoption of healthcare services in Asia- Pacific. This, in turn, is the major factor providing a growth opportunity for the medical suction devices market in the region.

The report covers:
Comprehensive research methodology of global Medical suction devices market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global Medical suction devices market.
Insights about market determinants which are stimulating the global Medical suction devices market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit https://www.omrglobal.com/reports-category/medical-devices/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:

LinkedIn

Global Medical Suction Devices Market Research By Orion Market Research


Source: EIN Presswire